Skip to main content
SpringerLink
Log in
Book cover

Pocket Handbook of GI Pharmacotherapeutics pp 113–137Cite as

Hepatitis

  • Chapter
  • First Online:

  • 930 Accesses

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

This chapter will provide an overview of the treatment approach to the management of chronic hepatitis B and alcoholic hepatitis as well as treatment options for chronic hepatitis C and autoimmune hepatitis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

ADV:

Adefovir

Alt:

Alternative

cont:

Continue

ETV:

Entecavir

HCC:

Hepatocellular carcinoma

LAM:

Lamivudine

LdT:

Telbivudine

mcg:

Micrograms

mo:

Month

Rx:

Treat

TDF:

Tenofovir disoproxil fumarate

ULN:

Upper limit of normal

wk:

Week

y:

Year

References

  1. Terrault NA, Bzowej NH, Chang K-M, Hwang JP, Jonas MM, Hassan Murad M. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2015;63(1):261–83.

    Article  PubMed  Google Scholar 

  2. Lok ASF, Mcmahon BJ. AASLD Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.

    Google Scholar 

  3. Lok ASF, Mcmahon BJ. AASLD Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.

    Google Scholar 

  4. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213.

    Article  CAS  PubMed  Google Scholar 

  5. Bath RK, Wu GY. Autoimmune Hepatitis. BMJ Best Practice. http://bestpractice.bmj.com/best-practice/monograph/130.html. Accessed 08 July 2015.

  6. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932–54.

    Article  Google Scholar 

  7. LexiComp

    Google Scholar 

  8. UpToDate Drug Information

    Google Scholar 

  9. Rambaldi A, et al. Systematic review: glucocorticosteroids for alcoholic hepatitis—a Cochran Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167–78.

    Article  CAS  PubMed  Google Scholar 

  10. Amini M, Runyon B. Alcoholic hepatitis 2010: a clinician’s guide to diagnosis and therapy. World J Gastroenterol. 2010;16(39):4905–12.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Krishna B, et al. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol. 2009;15(13):1613–9.

    Article  Google Scholar 

  12. Akriviadis E, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637–48.

    Article  CAS  PubMed  Google Scholar 

  13. Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Aliment Pharmacol Ther. 2009;30:3–13.

    Article  CAS  PubMed  Google Scholar 

  14. Lucey MR, et al. Alcoholic hepatitis. N Engl J Med. 2009;360(26):2758–69.

    Article  CAS  PubMed  Google Scholar 

  15. O’Shea RS, et al. Alcoholic liver disease. AASLD practice guidelines. Hepatology. 2010;51(1):307–28.

    Article  PubMed  Google Scholar 

  16. Sovaldi [package insert]. Gilead Sciences Inc., Foster City, CA; 2015, Harvoni [package insert]. Gilead Sciences Inc., Foster City, CA; 2016, Olysio [package insert]. Janssen Therapeutics., Titusville, NJ; 2016, Daklinza [package insert]. Bristol-Myers Squibb Company., Princeton, NJ; 2016, ViekiraPak [package insert]. AbbVie Inc., North Chicago, IL; 2015, Technivie [package insert]. AbbVie Inc., North Chicago, IL; 2015

    Google Scholar 

  17. Feldman M (2010) Sleisenger & Fordtran’s gastrointestinal and liver disease. 9th edn, vol 2, Section 9, Chapter 84, alcoholic liver disease.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology-Hepatology Fellowship Program, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030-1845, USA

    Roopjeet K. Bath M.D.

  2. Division of Gastroenterology-Hepatology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030-1845, USA

    George Y. Wu M.D., Ph.D.

Authors
  1. Roopjeet K. Bath M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Y. Wu M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roopjeet K. Bath M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, Connecticut, USA

    George Y. Wu

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bath, R.K., Wu, G.Y. (2016). Hepatitis. In: Wu, G. (eds) Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-33317-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33317-5_8

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-33315-1

  • Online ISBN: 978-3-319-33317-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation